Clinical Trial Diversity: Data Points to Structural, Not Patient-Specific Solutions

Minorities are more likely to participate in cancer clinical trials than white people, but they are less likely to get the chance to say yes, highlighting the importance of bringing studies to different locations if sponsors are to be successful at increasing diversity.